217
Participants
Start Date
April 6, 2021
Primary Completion Date
September 29, 2023
Study Completion Date
September 29, 2023
Guardian™ Connect system, InPen™ Basal smart cap, smart insulin pens, and InPen™ Diabetes Management app
Guardian™ Connect system consists of Guardian™ Connect app, Guardian™ Connect transmitter, and Guardian Sensor (3), will be working with InPen™ Basal smart cap and smart insulin pens and InPen™ Diabetes Management app for multiple daily injections. The subject's insulin delivery, sleep, physical activity (as applicable), food intake data, and medication (as applicable) will be collected through applications with meal logging and medication requiring manual entry. In addition, subjects may also participate in optional self-administered insulin injection video capture and upload using a secure cloud-based site and/or monthly menstrual cycle logging using Apple Health and/or cardiac monitoring using BodyGuardian MINI.
Endocrine and Metabolic Consultants, Rockville
Endocrine Research Solutions, Inc., Roswell
Atlanta Diabetes Associates, Atlanta
AM Diabetes and Endocrinology Center, Bartlett
Arkansas Diabetes and Endocrinology Center, Little Rock
Texas Diabetes and Endocrinology, Round Rock
Texas Diabetes and Endocrinology, Austin
Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls
Mary and Dick Allen Diabetes Center, Newport Beach
Rainer Clinical Research Center, Renton
Loma Linda University Medical Center, Loma Linda
Salinas Valley Memorial Healthcare System, Salinas
Barbara Davis Center for Childhood Diabetes, Aurora
Rhode Island Hospital (Lifespan Clinical Research Center), Providence
Medtronic Diabetes
INDUSTRY